OppenheimerFunds’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $22.3M | Sell |
349,581
-21,966
| -6% | -$1.4M | 0.03% | 504 |
|
|
2018
Q4 | $19M | Buy |
371,547
+35,142
| +10% | +$1.79M | 0.03% | 527 |
|
|
2018
Q3 | $19.5M | Sell |
336,405
-147,405
| -30% | -$8.55M | 0.02% | 589 |
|
|
2018
Q2 | $23.5M | Buy |
483,810
+26,052
| +6% | +$1.26M | 0.03% | 540 |
|
|
2018
Q1 | $21.3M | Buy |
457,758
+444,009
| +3,229% | +$20.6M | 0.03% | 550 |
|
|
2017
Q4 | $517K | Sell |
13,749
-504,150
| -97% | -$19M | ﹤0.01% | 1505 |
|
|
2017
Q3 | $18.9M | Sell |
517,899
-227,757
| -31% | -$8.3M | 0.02% | 582 |
|
|
2017
Q2 | $29.4M | Sell |
745,656
-192,834
| -21% | -$7.6M | 0.04% | 434 |
|
|
2017
Q1 | $29.4M | Sell |
938,490
-465,765
| -33% | -$14.6M | 0.04% | 452 |
|
|
2016
Q4 | $43.9M | Buy |
1,404,255
+531,966
| +61% | +$16.6M | 0.06% | 352 |
|
|
2016
Q3 | $35.1M | Buy |
872,289
+20,019
| +2% | +$804K | 0.04% | 415 |
|
|
2016
Q2 | $28.3M | Sell |
852,270
-480,645
| -36% | -$16M | 0.04% | 463 |
|
|
2016
Q1 | $39.2M | Buy |
1,332,915
+465,870
| +54% | +$13.7M | 0.05% | 378 |
|
|
2015
Q4 | $22.8M | Buy |
867,045
+95,325
| +12% | +$2.51M | 0.03% | 527 |
|
|
2015
Q3 | $18.3M | Buy |
771,720
+82,980
| +12% | +$1.97M | 0.02% | 568 |
|
|
2015
Q2 | $16.4M | Sell |
688,740
-218,460
| -24% | -$5.19M | 0.02% | 637 |
|
|
2015
Q1 | $21.5M | Buy |
907,200
+46,020
| +5% | +$1.09M | 0.02% | 575 |
|
|
2014
Q4 | $18.3M | Buy |
861,180
+144,960
| +20% | +$3.08M | 0.02% | 608 |
|
|
2014
Q3 | $12.2M | Buy |
+716,220
| New | +$12.2M | 0.01% | 700 |
|